POET Technologies Banks on Blazar and $500M Lumilens Deal to Navigate Class-Action and Market Slump
Published on 07/20/2026 at 13:53 | Redaktion boerse-global.de
The optics-chip developer POET Technologies has stopped accepting new customer orders for the next twelve months — a logistical bottleneck that many companies would envy, but one that also underscores the immense pressure the firm faces to scale up production. Shares have been caught in a violent downdraft alongside the broader semiconductor selloff, sliding 37.73% over the past 30 days to close Monday at €6.65, a modest 1.99% gain from Friday. That still leaves the stock 64.70% below its 52-week high of €18.84 set on May 15, 2026.
The selling pressure is amplified by a class-action lawsuit filed by Bronstein, Gewirtz and Grossman, which accuses POET of violating U.S. securities law over the period April 1–27, 2026. The complaint alleges the company misrepresented its PFIC tax status and that Thomas Mika breached a confidentiality agreement. The lead-plaintiff deadline passed on June 29, but the legal uncertainty continues to fuel wild swings in the stock: annualized 30-day volatility hovers around 96.5%, and the relative strength index of 36 signals an oversold condition.
A $400 million capital raise at $21 per share has given POET plenty of runway, yet the stock quickly sank below $8 — prompting at least one analyst to upgrade the name to Strong Buy, citing a post-raise cash position of roughly $817 million and management’s target of 1 million optical engine units per month by the end of 2027. 24/7 Wall Street also maintains a buy rating with a 2026 price target of $22.23 — implying 163% upside from the recent $8.46 level — albeit with just 50% conviction. The firm’s longer-range forecast reaches $125.44 by 2030.
Should investors sell immediately? Or is it worth buying POET Technologies?
To hit those production numbers, POET is racing to expand its workforce from roughly 115 employees today to about 165 by year-end, and plans to invest an additional $50 million in manufacturing equipment during the second half of 2026. The capacity squeeze is so acute that the company is turning away new clients entirely. On the product front, the next big catalyst is Blazar, an external-cavity laser still in prototype phase that was demonstrated at the OFC 2026 conference. Sample shipments to potential customers are slated for this year, with design wins anticipated in 2027 and series production in 2028.
The existing order book already points to accelerating revenue. First-quarter 2026 sales came in at $503,389, up 201.9% year over year, though the company posted a loss of $0.08 per share. For the full year, POET has guided for 30,000 optical engines. The Lumilens partnership is the most visible growth engine: what started as a $50 million initial order in 2027 has the potential to scale to more than $500 million over five years. Annual revenue from current customer relationships is estimated at around $100 million.
Big institutional names are taking notice. Citadel holds between 5.1% and 5.9% of the stock, while Jane Street owns 6.8%. Yet the macro backdrop is unforgiving: the Philadelphia semiconductor index has entered a bear market, and industry heavyweight TSMC is under pressure despite multibillion-dollar investment pledges in Arizona. For POET, the path forward depends on converting its optical-interposer platform and Blazar pipeline into firm orders faster than legal and sector headwinds can erode investor confidence.
Ad
POET Technologies Stock: New Analysis - 20 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
